Centers for Disease Control and Prevention Director Rochelle Walensky, M.D., last night recommended 12-15 year olds receive a single booster dose of the Pfizer COVID-19 vaccine at least five months after the initial two-dose series, expanding the agency’s recommendation for 16 and 17 year olds to younger adolescents. 

“Today, I endorsed ACIP’s vote to expand eligibility and strengthen our recommendations for booster doses,” Walensky said. “We now recommend that all adolescents aged 12-17 years should receive a booster shot 5 months after their primary series. This booster dose will provide optimized protection against COVID-19 and the Omicron variant. I encourage all parents to keep their children up to date with CDC’s COVID-19 vaccine recommendations.”

The Food and Drug Administration on Jan. 3 authorized a single booster dose of the Pfizer COVID-19 vaccine for 12-15 year olds, in addition to the previously authorized 16 and 17 year olds. 
 

Related News Articles

Headline
The Centers for Disease Control and Prevention Dec. 11 released a report that found last year’s version of the COVID-19 vaccine was 76% effective in preventing…
Headline
The AHA provided recommendations to the Food and Drug Administration Dec. 1 in response to a request for information on the measurement and evaluation of…
Headline
The Food and Drug Administration has identified a Class I recall of Baxter Life2000 Ventilation Systems due to a cybersecurity issue discovered through…
Headline
The Food and Drug Administration yesterday published an announcement from Otsuka ICU Medical saying that the company issued a voluntary recall for a mislabeled…
Headline
The Centers for Disease Control and Prevention will update its immunization schedules for the COVID-19 and chickenpox vaccines to adopt recent recommendations…
Headline
The Food and Drug Administration today issued a request for public comment on a series of questions regarding current approaches to evaluating artificial…